Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The aim of this study is to evaluate the efficacy and safety of pazopanib compared with placebo in patients with T < or = 5 cm, N0 (stage I according to TNM 2009) completely resected NSCLC.
Critère d'inclusion
- Carcinoma, Non-Small-Cell Lung